article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Bonus Features – September 24, 2023 – 72 percent of patients say affordability is the biggest challenge for paying medical bills

Healthcare IT Today

Collaborations between AI vendors and biotech/pharma companies over the last five years are worth more than $45 billion , according to a recent report from Accenture. Risk management vendor Censinet, KLAS Research, the AHA, and others are launching Wave 3 of The Healthcare Cybersecurity Benchmarking Study.

article thumbnail

The U.S. BIOSECURE Act Misses the Urgent Need to Secure DNA Data

Healthcare IT Today

and the Chinese Communist Party (CCP) and House Select Subcommittee on the Coronavirus Pandemic, the BIOSECURE Act is intended to control the biotech supply chain and secure citizens’ genetic data. Where the BIOSECURE Act Falls Short According to the House Select Committee on the Strategic Competition Between the U.S.

BioTech 70